Plain-English translation of NCT05403177 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Breast Cancer research guide →This is a research study that collects tumor tissue and blood samples from cancer patients to map out the genetic makeup of their cancer. The goal is to use advanced genetic testing and artificial intelligence to figure out which treatments will work best for each individual patient, so doctors can give the right treatment at the right time.
Right now, cancer treatment is often a one-size-fits-all approach, but we know that different patients respond differently to the same drugs. This study exists to gather the genetic information needed to personalize cancer care so that patients get treatments matched specifically to their tumor's unique characteristics.
You likely qualify if…
You likely don't qualify if…
If you join this study, you'll donate tumor tissue and blood samples that researchers will analyze using advanced genetic testing and artificial intelligence tools. You may also share your medical records, pathology reports, and imaging results. Depending on what samples are already available, you might be asked to undergo a fresh biopsy or blood draw. Researchers will track your treatment outcomes over time to see how well the genetic predictions match real-world results.
AI-generated summary from trial data · Jun 18, 2026 · Not medical advice
Canada